Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products. The company is also involved in multiple Institutional Review Board (IRB)-approved clinical studies.
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
Adia Med sold a 30% stake in its Adia Labs subsidiary to Live Oak Health (dba QCM Biologics) for $1.5 million, structured as $1.0 million cash plus a $500,000 promissory note.
The deal includes a two-year option for Live Oak to buy an additional 10% for $500,000, and pairs the sale with an exclusive distribution arrangement under which QCM Biologics sells Adia Labs products through its existing sales force.
The transaction adds an external distribution channel without internal build-out costs, though half the consideration is a note rather than cash and the proceeds go to Adia Labs rather than the parent.